Bioquell Group Sites

Applications Engineer

Software / Controls engineer

Test Technician

Senior Production Engineer

Contact Us

BioxyQuell

Quality

Bioquell links

Micro News

Downloads

Enquiry

Media/Press Centre

Scientific references

Material Compatibility

Sectors

Applications

Solutions

Markets

Events

Filtration technology

Aqueous oxygen peroxide

Careers with Bioquell

Maps and addresses

Bioquell global

Bioquell PLC

Our heritage

Efficacy

Microbiology

Hydrogen peroxide vapour

Accessibility

Copyright

Case Studies

Privacy policy

Terms and Conditions

Resources

Contact

About us

Consumables / parts

Technology

Products

Professional Bio-decontamination Services

Applications Engineer

An extremely exciting opportunity has arisen to combine the development of an engineering career dealing with major armoured vehicle manufacturers together with some worldwide travel, within a company that offers good prospects for career development.

Company Profile:

Bioquell Defence is a division of Bioquell UK Ltd. and is one of the UK’s leading manufacturers of contamination control equipment. Bioquell Defence has over 40 years experience in the research, design, development, production and support of Nuclear, Biological and Chemical filtration systems and Crew Cooling Units for armoured fighting vehicles, ships and shelters within the defence industry. Products include:

Vehicle CBRN systems
Vehicle crew cooling and heating units
Unhardened Collective Protection (COLPRO) systems
Range of NBC filters
Support equipment including inertial separators, pressure relief valves and engine air filters

Job Specification:

A mechanical design engineer is required to support the Defence Sales Team to develop and market existing and new products and will be involved throughout the complete product range from design to sales, manufacturing and product support.

The successful candidate will be qualified to a good Degree standard, HNC or equivalent in Mechanical Engineering, with an aptitude for thermodynamics and refrigeration. Experience of design using CAD systems, preferably ProE, is essential. Work experience in a design environment would be highly desirable and some experience with Defence and/or Automotive equipment and automotive air conditioning would also be an advantage.

The person must be capable of integrating into the Bioquell Defence team and Bioquell Engineering, and working to tight time scales in a varied environment. This is likely to include working away from home for short periods both in UK and overseas, and on occasions working beyond normal hours.

A flexible approach will be required as the successful candidate will undertake a wide range of duties as part of their role within the Defence team.

Main Tasks

Work in conjunction with other members of the Defence Sales and Bioquell Engineering teams to produce concepts, design schemes and studies for CBRN air filtration systems and air conditioning systems for use on fighting vehicles and military shelters.
Assist with costing of the schemes as prepared above.
Assist with preparation of quotations and proposals for selling these systems to the customer.
Preparation of detailed schemes suitable for preparation of final detail drawings, and checking of resultant detail drawings and bills of materials. Preparation of drawings for smaller projects.
Provide technical assistance to Bioquell Defence sales and marketing both in house and at meetings with customers.

For more information or to apply directly for this position, contact Bridget Goddard on bridget.goddard@bioquell.com

NO AGENCIES PLEASE

Software / Controls engineer

Job Title: Software / Controls Engineer.

Department: Technical Department.

Reports to: Controls Manager.

Background:

Bioquell is a leading supplier of Bio-Decontamination equipment, based on hydrogen peroxide vapour. With the expansion of the business, there is now a requirement for a Controls Engineer.

Qualification & Experience:

HND, Degree or similar
Experience and knowledge of programming in VB and C is important and working with SQL databases would be advantageous
Knowledge on PCB design and wiring is not essential but would be beneficial
Must be able to show ability to work within larger design teams of different disciplines as well as with clients which may be on their site.
Must be able to demonstrate they can be hands on and fault find on the products.
Experience of Siemens PLC (S200 series) software will be advantageous

Responsibilities:

Writing Code for PIC Chips and other microprocessors to operate pharmaceutical type equipment. Testing and documentation of the programs to rigorous industry standards
Writing PLC code for products and interfaces with Facility systems, testing and documentation of the code. Some of the testing and finalising of parameters may be on overseas sites.
Design of systems to store in databases for both in house testing results and in products with appropriate access security

Package:

Salary: c. £25-35k
Holiday: 20 days, rising 1 day per year to max. 25 days
Contributable pension scheme: employee 3% / employer 6%
Life assurance scheme: 3x salary
Annual appraisal / salary review

For more information or to apply directly for this position, contact Bridget Goddard on bridget.goddard@bioquell.com

NO AGENCIES PLEASE

Test Technician

Job Specification for a Test Technician

Role Summary/Purpose	The Test Technician is responsible for the defined factory qualification testing of a range of bio-decontamination equipment with moderate complexity. This role follows an individual work plan and meets day-to-day short term objectives. The successful candidate will have the ability to resolve issues through immediate action.
Essential Responsibilities	Perform and analyse testing of existing and new products for manufacturing as directed by the manufacturing team leaders. Carry out various electrical and mechanical measurements using a mix of standard and dedicated test equipment. Taking measurements, logging results and complying with written procedures and instructions Highlight any build quality issues found. Assist in the continuous improvement of testing processes through observation and recommendation.
Qualifications/Requirements	Previous experience in production testing of electro-mechanical products in a mid volume manufacturing environment. Ability to test down to component level and carry out repairs on a day-to-day basis. ONC/OND level qualification in electro-mechanical engineering or other relevant discipline. Ability to read circuit diagrams. Ability to use basic test equipment. PC literate including MS office skills. Strong problem solving skills. Clear and concise written communication skills. Good interpersonal skills. Keen attention to detail. Methodical working practices.
Desired Characteristics	Experience in testing of medical devices. Experience of working within a lean manufacturing environment.
Package	Annual pay / bonus review 20 days holiday, rising 1 day per annum to maximum of 25 days holiday excellent contributory pension scheme (employee 3% / employer 6%) 3x salary annual life assurance Annual appraisal scheme and regular training programme Cycle to work / childcare voucher scheme Chance to work for a rapidly expanding and world-renowned engineering company! For more information or to apply directly for this position, contact Bridget Goddard on bridget.goddard@bioquell.com NO AGENCIES PLEASE

Senior Production Engineer

Role: Senior Production Engineer

Department: Production Engineering

Qualifications: Degree level in Mechanical, Electrical or Manufacturing Engineering

Post graduate experience in business associated with build and test of electro-mechanical assemblies is preferable.

The candidate will be able to demonstrate awareness and site examples of success in selecting and implementing best practice ‘lean’ process within an assembly environment. The role will cover both continuous improvement of existing production process, development of new process and NPI activities. The candidate will require excellent interpersonal skills as they will be required to interact at all levels within the business.

The ability to develop production cell concepts including, layout, process flow, capacity models, tooling and fixtures is essential and must include CAD skills, preferably using ProENG or AutoCAD.

General IT skills using MS office products is required and the candidate would be expected to be able to create professional reports, capital expenditure justifications and process documentation based on robust data analysis. The company uses an ERP system and the candidate would be expected to be capable of developing and maintaining system BOMs and routings based on assembly drawings and time studies.

Package:

annual pay / bonus review
20 days holiday, rising 1 day per annum to maximum of 25 days holiday
excellent contributory pension scheme (employee 3% / employer 6%)
3x salary annual life assurance
annual appraisal scheme and regular training programme
cycle to work / childcare voucher scheme
the chance to work for a rapidly expanding and world-renowned engineering company!

For more information or to apply directly for this position, contact Bridget Goddard on bridget.goddard@bioquell.com

Contact Us

In order to advise you better on the optimal technology / solution for your application, please provide us with the following information.

Please complete all fields marked with an *.

About you

Salutation

First Name Last Name*

Phone* Email*

Job Title* Company*

City State/Province

Country*

Your Enquiry

Information

Email Opt Out

BioxyQuell

Bioquell’s research scientists are developing the BioxyQuellwound treatment unit, a system that produces and applies an aqueous oxygen peroxide based antimicrobial solution for cleansing wounds. The solution is residue-free, breaking down into the natural products oxygen and water. This novel, patent protected technology is currently undergoing clinical trials and will be submitted to medical device regulators for approval.

The BioxyQuellaqueous oxygen peroxide solution can also be applied in a wide range of industrial applications where powerful, residue free biodecontamination is required.

Quality

Bioquell has developed its business significantly over recent years and is now an international market leader in the field of bio-decontamination, including specialist filtration and the provision of peroxide-based decontamination solutions. We are committed to providing our clients with world-class products and services and the Bioquell UK manufacturing business has implemented a quality management system which meets the requirements of BS EN ISO 9001:2008 and BS EN ISO 13485:2003.

The latest certificates are available in the download section on this page.

Bioquell links

Link for Bioquell Proactive service customers - Bioquell QuAD data login page

Link for Bioquell e-Services customers - Bioquell e-Services Training Portal

Astec-microflow Biological safety cabinets and Fume cupboards

Micro News

Micro News is written by Bioquell microbiologists Dr Jon Otter and Dr Saber Yezli. The news includes articles identified by a PUBMED search using the terms ‘MRSA’, ‘VRE’, ‘Acinetobacter’ and ‘Clostridium difficile’ and through monthly review of the Journal of Hospital infection, the British Journal of Infection Control, Infection Control and Hospital Epidemiology and the American Journal of Infection Control.

Articles are included in the review if they are focussed on environmental microbiology in the healthcare setting. To subscribe to Micro News, please contact us and ask for your name to be added to our distribution list.

> Contact Us

Downloads

Enquiry

Media/Press Centre

Welcome to the Bioquell Media/Press Centre. On our site you’ll find quick, easy access to Bioquell's technology and details of our global operations.

Be sure to check in regularly for the latest updates. And if you need more information, please contact Martin Whiting, Marketing Director and Press Communications on info@bioquell.com or by telephone +44 (0)1264 835 835.

Complete press kits are available on request.

> Contact Us

Scientific references

The efficacy and ease-of-use of Bioquell's hydrogen peroxide vapour technology has been proven time and time again in leading peer-reviewed scientific publications. Below is a comprehensive list of the references to these articles.

Papers relating to Bioquell hydrogen peroxide vapour (HPV)
(generated from 30%-35% w/w hydrogen peroxide solution)

Andersen BM. Does 'airborne' hydrogen peroxide kill Mycobacterium tuberculosis? J Hosp Infect 2010 in press.

Lawley TD, Clare S, Deakin LJ, Goulding D, Yen JL, Raisen C, Brandt C, Lovell J, Cooke F, Clark TG, Dougan G. Purified Clostridium difficile spores facilitate the evaluation of healthcare disinfection regimens. Appl Environ Microbiol 2010;76:6895-8900.

Otter JA, Yezli S. A call for clarity when discussing hydrogen peroxide vapour and aerosol systems. J Hosp Infect, in press.

Otter JA, Havill NL, Boyce JM. Hydrogen peroxide vapor is not the same as aerosolized hydrogen peroxide. Infect Control Hosp Epidemiol 2010;31:1201-1202.

Otter JA, Yezli S, Schouten MA, van Zanten ARH, Houmes-Zielman G, Nohlmans-Paulssen. Hydrogen peroxide vapor (HPV) decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant Gram-negative rods during an outbreak. Am J Infect Control 2010;38:754-756.

Otter JA, Barnicoat M, Down J, Smyth D, Yezli S, Jeanes A. Hydrogen peroxide vapor (HPV) decontamination of an intensive care unit room used to treat a patient with Lassa fever. J Hosp Infect 2010;75:335-337.

Otter JA, Yezli S. Cycle times for hydrogen peroxide vapour decontamination. Can J Microbiol 2010;56:356-257.

Pottage T, Richardson C, Parks S, Walker JT, Bennett AM. Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses. J Hosp Infect 2010;74:55-61.

Otter JA, Puchowicz M, Ryan D, Salkeld JA, Cooper TA, Havill NL, Tuozzo K, Boyce JM. Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Control Hosp Epidemiol 2009;30:574-547.

Otter JA, Budde-Niekiel A. Hydrogen peroxide vapor: a novel method for the environmental control of lactococcal bacteriophages. J Food Prot 2009;72:412-414.

Otter JA, French GL. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapour (HPV). J Clin Microbiol 2009;47:205-207.

Unger-Bimczok B, Kottke V, Hertel C, Rauschnabel J. The Influence of Humidity, Hydrogen Peroxide Concentration, and Condensation on the Inactivation of Geobacillus stearothermophilus Spores with Hydrogen Peroxide Vapor. J Pharm Innov 2008;3:123-33.

Boyce JM, Havill NL, Otter JA, McDonald LC, Adams NM, Thompson A, Wiggs L, Noble-Wang J. Impact of hydrogen peroxide vapor room bio-decontamination on environmental contamination and nosocomial transmission of Clostridium difficile. Infect Cont Hosp Epidemiol 2008;29:723-729.

Dryden M, Parnaby R, Dailly S, Lewis T, Davis-Blues K, Otter JA, Kearns AM.Hydrogen peroxide vapor (HPV) decontamination in the control of a polyclonal MRSA outbreak on a surgical ward. J Hosp Infect 2008;68:190-192.

Hall L, Otter JA, Chewins J, Wengenack NL. Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor. Med Mycol 2008;46:189-191.

Otter JA, Chewins C, Windsor D, Windsor H. Microbial contamination in cell culture: a potential role for hydrogen peroxide vapour (HPV)? Cell Biol Int 2008;32:326-327.

Otter JA, Cummins M, Ahmad F, van Tonder C, Drabu YJ. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007;67:182-188.

Hall L, Otter JA, Chewins J, Wengenack NL. Use of hydrogen peroxide vapour for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 2007;45:810-815.

Hardy KJ, Gossain S, Henderson N, Drugan C, Oppenheim BA, Gao F et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007;66:360-368.

Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007; 65 Suppl 2:S50-54.

Otter JA, French GL, Adams NM, Watling D, Parks MJ. Hydrogen peroxide vapour decontamination in an overcrowded tertiary care referral centre: some practical answers. J Hosp Infect 2006;62:384-385.

Rogers JV, Sabourin CL, Choi YW, Richter WR, Rudnicki DC, Riggs KB et al. Decontamination assessment of Bacillus anthracis, Bacillus subtilis, and Geobacillus stearothermophilus spores on indoor surfaces using an HPV generator. J Appl Microbiol 2005;99:739-748.

Bates CJ, Pearse R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J Hosp Infect 2005;61:364-366

Otter JA. Bio-deactivation of hospital pathogens. Health Estate 2005;59:41-44.

Johnston MD, Lawson S, Otter JA. Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 2005;60:403-411.

French GL, Otter JA, Shannon KP, Adams NM, Watling D, Parks MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 2004;57:31-37.

Watling D, Ryle C, Parks M, Christopher M. Theoretical analysis of the condensation of hydrogen peroxide gas and water vapour as used in surface decontamination. PDA J Pharm Sci Technol 2002;56:291-299.

Conference abstracts relating to Bioquell HPV

Goyal SM, Chander Y, Yezli S, Otter JA. Hydrogen peroxide vapor (HPV) inactivation of feline calicivirus, a surrogate for norovirus. 7th Hospital Infection Society International Conference, 10-13 October 2010, Liverpool, UK.

Otter JA, Barnicoat M, Down J, Smyth D, Yezli S, Jeanes A. Hydrogen peroxide vapor (HPV) decontamination of an intensive care unit room used to treat a patient with Lassa fever. 7th Hospital Infection Society International Conference, 10-13 October 2010, Liverpool, UK.

Otter JA, Yezli S, Bissell D. Hydrogen peroxide vapour (HPV) decontamination: a novel technology for the control of hospital acquired infections. Australian Infection Control Association Conference, 4-6 October 2010, Perth, Australia.

Adams NMT, Yezli S, Otter JA. Hydrogen peroxide vapour decontamination: a versatile method to tackle biological warfare agents and pathogens associated with hospital-acquired infections. 10th International Symposium on Protection Against Chemical and Biological Warefare Agents, 8-11 June 2010, Stockholm, Sweden.

Otter JA, Duclos M, Salkeld JAG, Nowakowski E, Passaretti CL, Perl TM. Decontamination of unused, packaged supplies contaminated with vancomycin-resistant enterococci (VRE) using hydrogen peroxide vapor (HPV). 5th Decennial Meeting of the Society for Healthcare Epidemiology of America (SHEA), Atlanta, GA, USA. Abstract 62. [Oral*] (Also presented at the Birmingham International Burns Congress, 5-7 September 2010, Birmingham UK. Abstract 13. [Poster].)

Manain F, Griesenauer S, Senkel D. Impact of an intensive terminal cleaning and disinfection (C/D) protocol involving selected hospital rooms on endemic nosocomial infection (NI) rates of common pathogens at a tertiary care medical center. 5th Decennial Meeting of the Society for Healthcare Epidemiology of America (SHEA), Atlanta, GA, USA. Abstract LB6. [Oral]

Manain F, Griesenauer S, Senkel D. Persistence of Acinetobacer baumannii complex (ABC) and methicillin-resistant Staphylococcus aureus (MRSA) in hospital rooms despite 4 rounds of terminal cleaning and disinfection (C/D): exploring a new strategy. 5th Decennial Meeting of the Society for Healthcare Epidemiology of America (SHEA), Atlanta, GA, USA. Abstract LB7. [Poster]

Donnegan NE. Vaporized Hydrogen Peroxide as a part of a control intervention during an outbreak of Acinetobacter in an ICU. Abstract 207. [Poster]

Yezli S, Millward L, Salkeld JAG, Park MJ, Otter JA. Routine use of hydrogen peroxide vapour decontamination in the NHS. Infection Prevention Society Annual Meeting. Harrogate, 2009. [Poster]

Cooper T, O’Leary M. Clinical impact and cost-benefit of routine, preventative HPV bio-decontamination in a UK hospital. Infection Prevention Society Annual Meeting. Harrogate, 2009. [Poster]

Passaretti CL, Otter JA, Lipsett P, Shangraw A, Myers J, Ross T, Carroll K, Perl TM. Adherence to Hydrogen Peroxide Vapor (HPV) decontamination reduces VRE acquisition in high-risk units. 48^th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)and the Infectious Diseases Society of America (IDSA). Washington DC, USA, 2008. Abstract K4124b. [Poster]

Otter JA, Davies B, Klein J, Watts T, Kearns AM, French GL. Identification and control of an outbreak of gentamicin-resistant, methicillin-susceptible Staphylococcus aureus on a neonatal unit. 13^th International Symposium on Staphylococci and Staphylococcal Infection (ISSSI), Cairns, Australia, 2008. [Oral]

Passaretti CL, Lipsett P, Otter JA, Speck K, Lee A, Ryan D, Salkeld JAG, Adams NMT, Ristaino P, Maragakis L, Ross T, Carroll K, Perl TM. Does hydrogen peroxide vapor (HPV) enhance decontamination for multidrug-resistant organisms (MDROs) in intensive care units (ICUs)? 18^th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Orlando, Florida, 2008. Abstract 177. [Poster]

Puchowicz M, Ryan D, Otter JA, Salkeld JAG, Cooper TA, Havill NL, Tuozzo K, Boyce JM. Feasibility of ongoing use of hydrogen peroxide vapor (HPV) technology to decontaminate rooms vacated by patients with multidrug-resistant organisms. 18^th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Orlando, Florida, 2008. [Poster]

Dryden M, Parnaby R, Dailly S, Lewis T, Davis-Blues K, Otter JA, Kearns AM.Environmental decontamination with hydrogen peroxide vapor (HPV) in the control of an MRSA outbreak. 47^th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2007, Chicago. [Poster]

Otter JA, Cummins M, Ahmad F, van Tonder C, Drabu Y. O19 Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. Int J Antimicrob Agents 2007;29 Suppl. 2:S4. (16^th Annual Meeting of the European Congress of Clinical Microbiology and Infectious Disesase (ECCMID)) [Oral]

Schouten M, Otter JA, van Zanten A, Houmes-Zielman G, Nohlmans-Paulssen M. P1692 Environmental decontamination of an intensive care unit to control outbreaks of multidrug-resistant Gram-negative rods using hydrogen peroxide vapour. Int J Antimicrob Agents 2007;29 Suppl. 2:S479. (16^th Annual Meeting of the European Congress of Clinical Microbiology and Infectious Disesase (ECCMID)) [Poster]

Boyce JM, Havill NL, Otter JA, McDonald LC, Adams NM, Thompson A, Wiggs L, Noble-Wang J. Impact of Hydrogen Peroxide Vapor Room Bio-Decontamination on Environmental Contamination and Nosocomial Transmission of Clostridium difficile. 16^th Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Chicago, Illinois, 2006. Abstract 155. [Oral]

Hall L, Otter JA, Chewins J, Wengenack NL. Use of hydrogen peroxide vapour for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. 105^th General Meeting of the American Society for Microbiology (ASM), Orlando, Florida, 2006. [Poster]

Hall L, Otter JA, Chewins J, Wengenack NL. Deactivation of dimorphic fungi using HPV. 16^th Congress of the International Society of Human and Animal Mycology (ISHAM), Paris, France, 2006. [Poster]

French GL, Shannon KP, Otter JA. Survival of nosocomial bacteria dried in air and killing by hydrogen peroxide vapour (HPV). 44^th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington DC, 2004. [Poster]

Other documents relating to Bioquell HPV

Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455.

UK Department of Health and Health Protection Agency. Clostridium difficile infection: how to deal with the problem. 2009. Available from http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_093220

UK Department of Health and NHS Purchasing and Supply Agency. HCAI Technology Innovation Programme. Showcase Hospitals report number 3. The Bioquell Hydrogen Peroxide Vapour (HPV) Disinfection System. Available from www.clean-safe-care.nhs.uk. 2009.

Rutala WA, Weber DJ and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008.

McAnoy AM. Vaporous Decontamination Methods: Potential Uses and Research Priorities for Chemical and Biological Contamination Control. Human Protection and Performance Division Defence Science and Technology Organisation. Department of Defence. Australian Government. 2006.

Healthcare Commission. Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust. July 2006.

Pellowe CM, Pratt RJ, Loveday HP, Harper P, Robinson N, Jones SRLJ. The epic project. Updating the evidence-base for national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England: a report with recommendations. Brit J Infect Control 2004;5:10-16.

UK case studies. Available at www.clean-safe-care.nhs.uk.

Material Compatibility

Bioquell's scientific research regularly conducts tests to ascertain the effect of hydrogen peroxide vapour (H₂O₂) on various commonly encountered materials which may be exposed to both dry and saturated H₂O₂ during a gassing cycle.

This helps to provide a robust indication as to the effects of H₂O₂ based on scientific evidence. The method of producing the hydrogen peroxide vapour throughout these tests is consistent and comparable across the entire range of Bioquell's hydrogen peroxide vapour decontamination equipment.

It is important to understand that the test cycles are intentionally designed to be generally more destructive than the actual gassing environment. They are intended to apply a severe exposure to the test material in order to ensure that, under normal gassing conditions, there no likelihood of damage.

Further, one-off gassing is far less likely to produce material compatibility problems as compared to repeated gassing on a daily basis.

To discuss testing, please contact Bioquell.

Sectors

Sectors page

Applications

This list outlines the various applications for HPV and filtration techonology across the healthcare, life sciences and defence industries.

Solutions

Solutions page

Markets

Bioquell specialises in three key market areas:

We have also developed our technology for use in the food processing/manufacture industry.

We are the world leader in providing hydrogen peroxide vapour (HPV) decontamination equipment and services into these markets.

Hydrogen peroxide vapour (HPV) bio-decontamination solutions developed by Bioquell have been used across the globe to eradicate problematic bacteria, viruses and fungi, throughout a wide range of applications. Bioquell’s unique HPV technology is used to bio-decontaminate rooms, equipment and electronic devices safely and as efficiently as possible, without leaving problematic residues associated with other traditional decontaminants such as formaldehyde or chlorine-based products. Moreover, the process is 'residue-free', breaking down to water vapour and oxygen – hence representing an extremely “green” or environmentally friendly biocide. The efficacy of the process has been validated using Tyvek^® pouched 6-log Geobacillus stearothermophilus (spore) biological indicators.

Events

Filtration technology

CBRN filters are designed to filter known chemical and biological warfare agents. The NATO standard No.1 composite filter, which combines UHE (Ultra High Efficiency) elements and charcoal beds in matching forms, is a highly efficient (99.997%) radial-flow unit consisting of the following two elements:

1. Charcoal filter - made from a high carbon content raw material. It is ‘activated’ with chemicals to open up the pores to produce a microscopic sponge-like material with a vast internal surface area. This makes the surface more active and receptive to known chemical warfare agents through a process of adsorption and chemisorbtion.

2. HEPA filters - composed of a mat of randomly arranged fibres. The fibres are typically composed of fibreglass of diameters between 0.5 and 2.0 microns. Key factors affecting function are fibre diameter, filter thickness and face velocity. The air space between HEPA filter fibres is much greater than 0.3 microns. The common assumption, that a HEPA filter acts like a sieve where particles smaller than the largest opening can pass through, is incorrect. HEPA filters are designed to target much smaller particles. These particles are trapped (by sticking to a fibre) through a combination of the following three mechanisms:

i. Interception, where particles following a line of flow in the air stream come within one radius of a fibre and adhere to it.
ii. Impaction, where larger particles are unable to avoid fibres by following the curving contours of the air stream and are forced to embed in one of them directly; this effect increases with diminishing fibre separation and higher airflow velocity.
iii. Diffusion, an enhancing mechanism is a result of the collision with gas molecules by the smallest particles, especially those below 0.1 µm in diameter. These are thereby impeded and delayed in their path through the filter; this behaviour is similar to Brownian motion and raises the probability that a particle will be stopped by either of the two mechanisms above; it becomes dominant at lower airflow velocities.

Cyclone filters are often used as a pre-filter to protect and prolong the life of CBRN filters. Inertial separators use cyclonic action to separate dust particles from the air stream. In a typical cyclone, the dust airstream enters at an angle and is spun rapidly. The centrifugal force created by the circular flow throws the dust particles toward the wall of the cyclone. After striking the wall, these particles fall into either a hopper located underneath or are removed by a secondary cyclone scavenge fan. Cyclones can achieve efficiencies as high as 97% when tested using BS 1701 coarse dust.

Aqueous oxygen peroxide

Bioquell has been involved in the development of ozone based decontamination systems for over 10 years. Products have been developed for pharmaceutical, food and healthcare industries using ozone in either its gaseous or, when dissolved into water, its aqueous form.

Aqueous oxygen peroxide, more commonly known as ozone, is a molecule comprising three atoms of oxygen. This triatomic arrangement is unstable, making ozone molecules highly reactive. Ozone is an oxidising agent - one of the most powerful known to man.

As ozone oxidises other compounds, it loses an oxygen atom and forms oxygen. This powerful oxidation effect, coupled with the formation of oxygen as the bi-product of the reaction, makes ozone an excellent biocide. Ozone is generated at point of use, eliminating the need to transport and store potentially hazardous chemicals.

Its natural decomposition to oxygen makes it environmentally friendly and sustainable.

BioxyQuell

Careers with Bioquell

Bioquell is the UK’s leading bio-decontamination specialist and home to some of the most talented and innovative people in the industry. We have a global reputation for excellence in the development and deployment of new and advanced bio-decontamination techniques. Our heritage and expertise also provide the basis for world-class training services.

Our success depends on the capability of our people, so we’re always looking for talented individuals to join our team. Whether working in research & development, manufacturing, sales & marketing or one of our corporate functions, we value people with an analytical mind, excellent communication skills and a keen eye for detail.

Please note that the Bioquell is not currently able to offer any work experience placements.

> Contact Us

Test Technician
Software / Controls Engineer
Applications Engineer

***NO AGENCIES PLEASE***

Bioquell will not respond to unsolicited enquiries from recruitment agencies

Maps and addresses

Visitors are welcome to visit the Bioquell offices. Please pre-arrange an appointment with your Bioquell contact before visiting.

Bioquell UK / Bioquell PLC
(Download map and directions from right-hand nav bar)

52 Royce Close
West Portway
Andover
Hampshire SP10 3TS
United Kingdom

T: +44 (0)1264 835 835
F: +44 (0)1264 835 836

> Contact Us

View Larger Map

Other Bioquell subsidiaries

Bioquell Ireland

Unit 4
Eastway Business Park
Ballysimon Road
Limerick
Ireland

T: +353 (0)61 603 622
F: +353 (0)61 603 627

View Larger Map


Bioquell France	153 quai du Rancy 94380 Bonneuil-sur-Marne Paris France T: +33 (0)1 43 78 15 94 F: +33 (0)1 43 78 15 84
Bioquell US	101 Witmer Road Suite 400 Horsham PA 19044 United States of America T: (215) 682 0225 F: (215) 682 0395
Bioquell Asia Pacific	Bioquell Asia Pacific Pte Ltd 207 Henderson Road #01-05 Singapore 155550 T: +65 6592 5145 F: +65 6227 5878
Bioquell China	Bioquell Technology (ShenZhen) Limited Room 2510B 25/F, Building Tiley Central Plaza No. 3 Haide Road Nanshan District, Shenzhen P.R.China. P.C: 518054 T: +86 755 8631 0348 F: +86 755 8631 0211

Bioquell global

Bioquell has expanded its operations to become a global leader in bio-decontamination technology.

It has operational bases in the UK, Ireland, France, USA, Singapore and China, supported by a range of distributors located throughout the world.

> Contact Us

Bioquell UK / Bioquell PLC	52 Royce Close West Portway Andover Hampshire SP10 3TS UK T: +44 (0)1264 835 835 F: +44 (0)1264 835 836
Bioquell Ireland	Unit E4 Eastway Business Park Ballysimon Road Limerick Ireland T: +353 (0)61 603 622 F: +353 (0)61 603 627
Bioquell France	153 Quai du Rancy 94380 Bonneuil-sur-Marne France T: +33 (0)1 43 78 15 94 F: +33 (0)1 43 78 15 84
Bioquell US	101 Witmer Road Suite 400 Horsham PA 19044 US T: (215) 682 0225 F: (215) 682 0395
Bioquell Asia Pacific	Bioquell Asia Pacific Pte Ltd 207 Henderson Road #01-05 Singapore 155550 T: +65 6592 5145 F: +65 6227 5878
Bioquell China	Bioquell Technology (ShenZhen) Limited Room 2510B 25/F, Building Tiley Central Plaza No. 3 Haide Road Nanshan District, Shenzhen P.R.China. P.C: 518054 T: +86 755 8631 0348 F: +86 755 8631 0211

Bioquell PLC

The Bioquell PLC Group comprises of two divisions; Bio-decontamination (which includes specialist hydrogen peroxide vapour bio-decontamination equipment for the pharmaceutical, life sciences and healthcare sectors, and chemical, biological, radiological and nuclear (CBRN) filtration products for the defence sector) and TRaC (which comprises of Testing, Regulatory and Compliance services).

Bio-decontamination division

Bioquell Hydrogen Peroxide Vapour (HPV) bio-decontamination equipment
Bioquell Professional Services, including Room Bio-Decontamination Service
Defence - Chemical, Biological, Radiological & Nuclear (CBRN) filtration equipment
Service - after sales customer service and support
Microflow™ & Astec™ laboratory filtration and containment equipment

TRaC division

TRaC EMC & Safety
TRaC Environmental & Analysis
TRaC Telecoms & Radio

Please visit our corporate investor site at www.bioquellplc.com to find out more about the group.

Our heritage

Bioquell is now the leading global supplier of bio-decontamination systems, led by advances developed in hydrogen peroxide vapour technology (HPV) over the last decade.

Built on a heritage of 'decontamination' technology, the original organisation was formed over 250 years ago, supplying plumbing and sanitation services to the public and private sector. This led to developments in flushing toilets/cisterns (including many installed at Royal residences and leading hospitals). As time progressed, work began to focus on developing advanced filtration products, leading to a range of fume cupboards and more recently laminar flow microbiological safety cabinets under the Astec and Microflow brand names. This filtration technology has also been employed in the defence sector providing chemical, biological, radioactive and nuclear (CBRN) protection for armoured vehicles, ships and aircraft.

Today, alongside the advanced CBRN protection, HPV bio-decontamination has been extensively developed. There is significant support to the efficacy of this unique Bioquell technology provided through numerous published peer-reviewed scientific papers. Bioquell is the clear market leader in the development and application of HPV technology, leading to many opportunities for deployment in the life science, healthcare, defence and food sectors.

Efficacy

Bioquell’s hydrogen peroxide vapour (HPV) is well established as a bio-decontamination agent due to its broad spectrum efficacy and its ability to inactivate rapidly the most resilient micro-organisms. The ‘residue-free’ nature of HPV (the only residues are oxygen and water) and low temperature, vapour phase application increases the utility of the process.

HPV has been tested against many organisms and classes of organisms. However, because a great number of ‘common’ microorganisms exist, efficacy testing remains an ongoing process.

You can download the latest HPV biological efficacy review document from the download section on the right-hand side of this page.

HPV has been shown to kill a wide range of micro-organisms including bacteria, viruses and fungi. The efficacy of HPV has been repeatedly demonstrated against bacterial endospores, which are the most resistant organisms commonly found on environmental surfaces, so are positioned at the top of the Spaulding classification.

The organisms listed in the HPV biological efficacy review document are divided into broad taxonomic categories (i.e. bacteria, viruses and fungi) and grouped according to their microbiological characteristics. This division allows for an easy comparison of an untested organism with other related organisms that have been tested. The appendix in this document includes the abstracts for the published journal articles.

Microbiology

Bioquell hydrogen peroxide vapour technology is effective against a wide range of microbes, including bacteria, mould, fungi and viruses. This section provides a scientific profile and background data on many of the common types of microbes that exist.

Hydrogen Peroxide Vapour

Bio-decontamination within a room or chamber is achieved by depositing an even layer of 'micro-condensation' of hydrogen peroxide vapour (HPV) over all surfaces. The term micro-condensation may be defined as a microscopic film of HPV, which being at a sub-micron level is invisible to the naked eye.

Scientific research has proven that it is this low temperature, 'residue-free' deposit that actually deactivates micro-organisms during the gassing process.

The micro-condensation process ensures that the optimum conditions for biological inactivation are achieved. When the process reaches the dew point the time required for a log reduction of activity (the D-Value) is shortest. This occurs when the kill kinetic curve plotted against time is steepest. The transition between the shallow curve and the steep section coincides with the onset of micro-condensation.

The combination of a vapour generator and high velocity gas distribution nozzles and fans provides an even spread of HPV vapour which can be introduced in the optimum combinations to all areas of a room or enclosure.

Utilising this system of active distribution, all surfaces are uniformly exposed to hydrogen peroxide vapour. This system is operated at ambient room temperature and relative humidity, without the need to attain significantly reduced humidity traditionally associated with hydrogen peroxide bio-decontamination systems.

Hydrogen peroxide vapour decomposes to oxygen and water vapour, hence the bio-decontamination process is 'residue-free'. The main benefit of this is that no further wiping down of surfaces is required on completion of decontamination.

Hydrogen peroxide vapour concentration is reduced to below a 1ppm concentration level, which is the current time-weighted average safe exposure limit, before re-entry to the room is permitted of hydrogen peroxide, via the vaporiser circuit.

Our video presentation below explains the HPV process in more detail.

> Find Out More

Accessibility

www.bioquell.com is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability.

We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines.

This website endeavours to conform to level Double-A of the World Wide Web Consortium (W3C) Web Content Accessibility Guidelines 2.0.

These guidelines explain how to make web content more accessible for people with disabilities. Conformance with these guidelines will help make the web more user friendly for all people.

This site has been built using code compliant with W3C standards for HTML and CSS. The site displays correctly in current browsers and using standards compliant HTML/CSS code means any future browsers will also display it correctly.

Whilst www.bioquell.com strive to adhere to the accepted guidelines and standards for accessibility and usability, it is not always possible to do so in all areas of the website.

We are continually seeking out solutions that will bring all areas of the site up to the same level of overall web accessibility. In the meantime should you experience any difficulty in accessing the www.bioquell.com website, please don’t hesitate to contact us.

Copyright

Intellectual Property Rights

Bioquell is the owner or the licensee of all intellectual property rights in this site, and in the material published on it. Those works are protected by copyright laws and treaties around the world. All such rights are reserved.
You may print off one copy, and may download extracts, of any page(s) from our site for your personal reference and you may draw the attention of others within your organisation to material posted on our site.

You must not modify the paper or digital copies of any materials you have printed off or downloaded in any way, and you must not use any illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text.

Our status (and that of any identified contributors) as the authors of material on our site must always be acknowledged.

You must not use any part of the materials on our site for commercial purposes without obtaining a licence to do so from us or our licensors.

If you print off, copy or download any part of our site in breach of these terms of use, your right to use our site will cease immediately and you must, at our option, return or destroy any copies of the materials you have made.

Trademarks

Bioquell is a registered trademark in the UK, Europe, US and other countries (list available on demand).

Case Studies

case studies text

Privacy policy

Privacy Policy - Overview

Bioquell UK Ltd is committed to protecting your privacy. The personal information we collect is only used internally to improve the services and information we provide.

What Information do we collect?
Two types of information are collected:

1. For normal visitors we collect information about your visit - IP address, browser type, pages visited, length of visit and such details. None of this type of information is linked to any individual.

2. Visitors who submit enquiries are asked for personal details so that we can answer the enquiries appropriately.

All the information collected is kept within the Bioquell group on secure servers.

We reserve the right to use cookies on the website.

Personal information is held in secure areas of the web server. None of it is accessible to online users without the use of passwords.

No information is disclosed to non-Bioquell individuals or organisations whatsoever.

Privacy Policy - Details

At Bioquell we are committed to protecting, preserving and respecting your privacy.
This policy (together with our terms of website use) sets out the basis on which any personal data we collect from you, or that you provide to us, will be processed by us. Please read the following carefully to understand our views and practices regarding your personal data and how we will treat it.
For the purpose of the Data Protection Act 1998 (the Act), the data controller is Bioquell UK Ltd of 52 Royce Close, West Portway, Andover, Hampshire, SP10 3TS.
INFORMATION WE MAY COLLECT FROM YOU
We may collect and process the following data about you:
• Information that you provide by filling in forms on www.bioquell.com (“our site”) such as when you register for information, or make a purchase. This includes information provided at the time of registering to use our site, subscribing to our service, posting material or requesting further services, or when you communicate with us electronically for any reason.

• We may also ask you for information when you report a problem with our site.

• If you contact us, we may keep a record of that correspondence.
• We may also ask you to complete surveys that we use for research purposes, although you do not have to respond to them.
• Details of transactions you carry out through our site and of the fulfilment of your orders.
• Details of your visits to our site including, but not limited to, traffic data, location data, weblogs and other communication data, whether this is required for our own billing purposes or otherwise and the resources that you access.
IP ADDRESSES AND COOKIES
We may collect information about your computer, including where available your IP address, operating system and browser type, for system administration and to report aggregate information to our advertisers. This is statistical data about our users' browsing actions and patterns, and does not identify any individual.
For the same reason, we may obtain information about your general internet usage by using a cookie file which is stored on the hard drive of your computer. Cookies contain information that is transferred to your computer's hard drive. They help us to improve our site and to deliver a better and more personalised service. They enable us:
• To estimate our audience size and usage pattern.
• To store information about your preferences, and so allow us to customise our site according to your individual interests.
• To speed up your searches.
• To recognise you when you return to our site.
You may refuse to accept cookies by activating the setting on your browser which allows you to refuse the setting of cookies. However, if you select this setting you may be unable to access certain parts of our site. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies when you log on to our site.
Please note that our advertisers may also use cookies, over which we have no control.
WHERE WE STORE YOUR PERSONAL DATA
The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area ("EEA"). It may also be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff maybe engaged in, among other things, the fulfilment of your order, the processing of your payment details and the provision of support services. By submitting your personal data, you agree to this transfer, storing or processing. We will take all steps reasonably necessary to ensure that your data is treated securely and in accordance with this privacy policy.
All information you provide to us is stored on our secure servers. Any payment transactions will be encrypted. Where we have given you (or where you have chosen) a password which enables you to access certain parts of our site, you are responsible for keeping this password confidential. We ask you not to share a password with anyone.
Unfortunately, the transmission of information via the internet is not completely secure. Athough we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our site; any transmission is at your own risk. Once we have received your information, we will use strict procedures and security features to try to prevent unauthorised access.
USES MADE OF THE INFORMATION
We use information held about you in the following ways:
• To ensure that content from our site is presented in the most effective manner for you and for your computer.
• To provide you with information, products or services that you request from us or which we feel may interest you, where you have consented to be contacted for such purposes.
• To carry out our obligations arising from any contracts entered into between you and us.
• To allow you to participate in interactive features of our service, when you choose to do so.
• To notify you about changes to our service.
We may also use your data, or permit selected third parties to use your data, to provide you with information about goods and services which may be of interest to you and we or they may contact you about these by any of the methods that you consented to at the time your information was collected.
If you are an existing customer, we will only contact you by electronic means (e-mail or SMS) with information about goods and services similar to those which were the subject of a previous sale to you.
If you are a new customer, we will contact you by electronic means only if you have consented to this.
If you do not want us to use your data in this way, please inform us, either through our website, or by writing to or emailing us (contact details set out below).
DISCLOSURE OF YOUR INFORMATION
We may disclose your personal information to any member of our group, which means our subsidiaries, our ultimate holding company and its subsidiaries, as defined in section 1159 of the Companies Act 2006.
We may disclose your personal information to third parties:
• In the event that we sell or buy any business or assets, in which case we may disclose your personal data to the prospective seller or buyer of such business or assets.
• If Bioquell or substantially all of its assets are acquired by a third party, in which case personal data held by it about its customers will be one of the transferred assets.
• If we are under a duty to disclose or share your personal data in order to comply with any legal obligation, or in order to enforce or apply our terms of use and other agreements; or to protect the rights, property, or safety of Bioquell, our customers, or others. This includes exchanging information with other companies and organisations for the purposes of fraud protection and credit risk reduction.
YOUR RIGHTS
You have the right to ask us not to process your personal data for marketing purposes. We will usually inform you (before collecting your data) if we intend to use your data for such purposes or if we intend to disclose your information to any third party for such purposes. You can exercise your right to prevent such processing by checking certain boxes on the forms we use to collect your data. You can also exercise the right at any time by contacting us at info@bioquell.com.
Our site may, from time to time, contain links to and from the websites of our partner networks, advertisers and affiliates. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.
ACCESS TO INFORMATION
The Act gives you the right to access information held about you. Your right of access can be exercised in accordance with the Act. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you. Please contact us if you wish to make such a request.
CHANGES TO OUR PRIVACY POLICY
Any changes we may make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.
CONTACT
Questions, comments and requests regarding this privacy policy are welcomed and should be addressed to:
Phone: +44 (0)1264 835835
Email: info@bioquell.com
Post: 52, Royce Close, West Portway, Andover, Hampshire, SP10 3TS

Terms and Conditions

This page explains the terms of use on which you may make use of our website www.bioquell.com (our site), whether as a guest or a registered user. Please read these terms of use carefully before you start to use the site. By using our site, you indicate that you accept these terms of use and that you agree to abide by them. If you do not agree to these terms of use, please refrain from using our site.

Information about us
This website site, www.bioquell.com is provided by Bioquell UK Ltd.

Accessing this site
Access to, and use of this site is permitted on a temporary basis, and we reserve the right to withdraw or amend the service we provide on our site without notice (see below). We will not be liable if for any reason our site is unavailable at any time or for any period.

You may not copy, reproduce, republish, download, post, broadcast, transmit or otherwise use the content of this website in any way except for your own personal, non-commercial use. You also agree not to adapt, alter or create a derivative work from any content on this website except for your own personal, non-commercial use. Any other use requires the prior written permission of Bioquell UK Ltd.

You agree to use the content of this website only for lawful purposes, and in a way that does not infringe the rights of, restrict or inhibit anyone else's use and enjoyment of the website.

By using our website you consent to the collection and use of information as described in this statement.

Any questions about privacy should be addressed to : info@bioquell.com

Links from our site
This website contains hyperlinks to websites operated by parties other than Bioquell UK Ltd. The operation of such websites is entirely outside the Bioquell's control and you proceed at your own risk. Bioquell does not endorse or sponsor the products, services or content you access through any linked site. These third party website have their own policies and practices with respect to online privacy.

Links to our site

You must not establish a link from any website that is not owned by you.

Our site must not be framed on any other site, nor may you create a link to any part of our site other than the home page. We reserve the right to withdraw linking permission without notice.

Liability Disclaimer

Bioquell UK Ltd uses reasonable endeavours to check the accuracy of information published on this website. You should note however that Bioquell does not warrant that such information will be error free and the user acknowledges that the information, products, and services published on this website may include inaccuracies or typographical errors. Changes are periodically made to the information herein.

Commentary and other materials posted on this site are not intended to amount to advice on which reliance should be placed. We therefore disclaim all liability and responsibility arising from any reliance placed on such materials by any visitor to our site, or by anyone who may be informed of any of its contents.

Acceptable Use Policy
This acceptable use policy sets out the terms between you and us under which you may access our website www.bioquell.com (our site). This acceptable use policy applies to all users of, and visitors to, our site.

You may use our site only for lawful purposes. You may not use our site:
a)     In any way that breaches any applicable local, national or international law or regulation; in any way that is unlawful or fraudulent, or has any unlawful or fraudulent purpose or effect; or for the purpose of harming or attempting to harm minors in any way.
b)     to transmit, or procure the sending of, any unsolicited or unauthorised advertising or promotional material or any other form of similar solicitation (spam); and
c)      to knowingly transmit any data, send or upload any material that contains viruses, Trojan horses, worms, time-bombs, keystroke loggers, spyware, adware or any other harmful programs or similar computer code designed to adversely affect the operation of any computer software or hardware.

You also agree:
a)     not to reproduce, duplicate, copy or re-sell any part of our site in contravention of the provisions of these terms of website use;
b)     not to access without authority, interfere with, damage or disrupt:
a.      any part of our site;
b.      any equipment or network on which our site is stored;
c.      any software used in the provision of our site; or
d.      any equipment or network or software owned or used by any third party.

Variations
If we make changes to this policy we will advertise them initially on the home page and incorporate them in this statement when they come into effect. You are expected to check this page from time to time to take notice of any changes we made, as they are binding on you. Some of the provisions contained in these terms of use may also be superseded by provisions or notices published elsewhere on our site.

General

If any of these terms are determined to be illegal, invalid or otherwise unenforceable by reason of the laws of any state or country in which these terms are intended to be effective, then to the extent and within the jurisdiction in which that term is illegal, invalid or unenforceable, it shall be severed and deleted from these terms and the remaining terms shall survive, remain in full force and effect and continue to be binding and enforceable.

Bioquell websites contain information about products which may or may not be available in any particular country, and if applicable, may have received approval or market clearance by a governmental regulatory body for different indications and restrictions in different countries. Each country has specific laws, regulations and medical practices governing the communication of medical or other information about medical products on the internet. Nothing herein should be construed as solicitation or promotion for any product or for an indication of any product, which is not authorised by the laws and regulations of the country where the reader resides.

This site may contain information on medical and health-related topics. This information is not meant to be a substitute for the advice provided by your own physician or other medical professional. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.

These terms shall be governed by and interpreted in accordance with the laws of England.

Resources

A range of Bioquell resources can be dowloaded from this website. To gain a wider access to the material available, please register and then log on to this site.

Contact

THIS SECTION IS NOT USED ON THIS PAGE

About us

Bioquell specialise in the design, manufacture and application of complete bio-decontamination solutions for airborne and surface contamination in the healthcare, life sciences, food production and defence sectors.

Bioquell's unique hydrogen peroxide vapour (HPV) bio-decontamination technology has been used across the globe to eradicate problematic bacteria, viruses and fungi, throughout a wide range of applications. Deployment of Bioquell's HPV process provides residue-free, safe and repeatable sterilisation of rooms, buildings, equipment and sensitive electronics.

It is a clear alternative when replacing traditional decontaminants such as formaldehyde or chlorine-based products.

Bioquell also provides bespoke chemical, biological, radioactive and nuclear (CBRN) filtration equipment for different applications in the defence industry. This equipment is complemented by integral air conditioning systems and auxiliary power units.

> Contact Us

Consumables / parts

Bioquell produces a range consumables and spare parts to complement its range of innovative bio-decontamination products and services.

Technology

Bioquell specialises in three key technologies:

Hydrogen peroxide vapour
Ozone technology
Advanced airborne gas and particulate filtering

This section explores the science behind our research and development innovations and provides an insight into how our products and services work.

Bio-decontamination Equipment

Bioquell produces a wide range of innovative bio-decontamination equipment/products using hydrogen peroxide vapour (HPV) technology.

Professional Bio-decontamination Services

Bioquell provides a wide range of professional decontamination services, enabling effective bio-decontamination of equipment through to large buildings.